An RNAi Screen Identifies Msi2 and Prox1 as Having Opposite Roles in the Regulation of Hematopoietic Stem Cell Activity

被引:121
|
作者
Hope, Kristin J. [1 ]
Cellot, Sonia [1 ]
Ting, Stephen B. [1 ]
MacRae, Tara [1 ]
Mayotte, Nadine [1 ]
Iscove, Norman N. [2 ]
Sauvageau, Guy [1 ]
机构
[1] Univ Montreal, IRIC, Mol Genet Stem Cells Lab, Montreal, PQ H3C 3J7, Canada
[2] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada
基金
加拿大创新基金会; 英国医学研究理事会;
关键词
BINDING PROTEIN MUSASHI; SELF-RENEWAL; ASYMMETRIC SEGREGATION; PROGENITOR CELLS; DIVISION; DIFFERENTIATION; DROSOPHILA; RECEPTORS; POLARITY; FAMILY;
D O I
10.1016/j.stem.2010.06.007
中图分类号
Q813 [细胞工程];
学科分类号
摘要
In this study, we describe an in vivo RNA interference functional genetics approach to evaluate the role of 20 different conserved polarity factors and fate determinants in mouse hematopoietic stem cell (HSC) activity. In total, this screen revealed three enhancers and one suppressor of HSC-derived reconstitution. Pard6a, Prkcz, and Msi2 shRNA-mediated depletion significantly impaired HSC repopulation. An in vitro promotion of differentiation was observed after the silencing of these genes, consistent with their function in regulating HSC self-renewal. Conversely, Prox1 knockdown led to in vivo accumulation of primitive and differentiated cells. HSC activity was also enhanced in vitro when Prox1 levels were experimentally reduced, identifying it as a potential antagonist of self-renewal. HSC engineered to overexpress Msi2 or Prox1 showed the reverse phenotype to those transduced with corresponding shRNA vectors. Gene expression profiling studies identified a number of known HSC and cell cycle regulators as potential downstream targets to Msi2 and Prox1
引用
收藏
页码:101 / 113
页数:13
相关论文
共 46 条
  • [41] MICROENVIRONMENTAL SFRP1 REGULATES REPOPULATING ACTIVITY OF HEMATOPOIETIC STEM CELLS VIA PP2A-MEDIATED REGULATION OF CTNNB1/EP300
    Hettler, Franziska
    Schreck, Christina
    Marquez, Sandra Romero
    Sippenauer, Theresa
    Koller, Franziska
    Demir, Ekin
    Bassermann, Florian
    Istvanffy, Rouzanna
    Oostendorp, Robert
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : S31 - S31
  • [42] Microenvironmental SFRP1 controls repopulating activity of Hematopoietic Stem Cells via PP2A-mediated regulation of CTNNB1/EP300
    Hettler, F.
    Schreck, C.
    Marquez, Romero S.
    Sippenauer, T.
    Koller, F.
    Demir, E.
    Bassermann, F.
    Istvanffy, R.
    Oostendorp, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 32 - 33
  • [43] Mouse bone marrow stromal cell line MC3T3-G2/PA6 with hematopoietic-supporting activity expresses high levels of stem cell antigen Sca-1
    Satoh, M
    Mioh, H
    Shiotsu, Y
    Ogawa, Y
    Tamaoki, T
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (09) : 972 - 979
  • [44] Sphingosine Kinase 2 (SphK2) Deficiency Does Not Lower but Instead Surprisingly Increases the Level of Sphingosine-1-Phosphate (S1P) in Peripheral Blood, Providing a Novel Strategy for Stimulating Hematopoietic Stem Cell Mobilization By Inhibiting SphK2 Activity
    Adamiak, Mateusz
    Chelvarajan, Lakshman
    Santos, Webster
    Lynch, Kevin R.
    Abdel-Latif, Ahmed
    Ratajczak, Mariusz Z.
    BLOOD, 2017, 130
  • [45] First-in-human phase 1/2 trial of intravenous FBX-101 following hematopoietic stem cell transplantation increases GALC activity, supports brain development, and improves motor function in patients with infantile Krabbe disease: RESKUE clinical trial
    Escolar, Maria L.
    Lugt, Mark Vander
    Poe, Michele
    Greco, Melissa
    Werling, Keith
    De Silva, Erandi
    Ruiz, Juan
    Szabolcs, Paul
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 39 - 39
  • [46] Intravenous FBX-101 (AAVrh10.hGALC) following Hematopoietic Stem Cell Transplantation increases GALC activity, supports brain development and improves motor function in Patients with Infantile Krabbe Disease: RESKUE Phase 1/2 Clinical Trial
    Escolar, M. L.
    Windreich, R.
    Poe, M.
    Greco, M.
    Werling, K.
    De Silva, E. K.
    Ruiz, J.
    Szabolcs, P.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A202 - A202